Janssen v. Pharmascience
We successfully represented Janssen in a motion brought by the appellant (Pharmascience) to settle the contents of the appeal book in the context of an appeal from the judgment of the Federal Court in Janssen Inc. v. Pharmascience Inc., 2022 FC 1218 [2022].
The issues of infringement and validity were bifurcated in the underlying action. The Federal Court of Appeal agreed with Janssen that materials from Pharmascience’s appeal of the infringement decision should be included its appeal of the validity decision.
